Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DCTPP1 | Q9H773 | 4/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.37 |
| ▸ | BRD4 | O60885 | 2/20 | 0.33 |
| ▸ | MDM4 | O15151 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | GLA | P06280 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31715131 | 0.93 | DCTPP1 (0.41) | DCTPP1CYP2C9CYP2C19CYP3A4KCNH2 | |
| SCHEMBL31715074 | 0.91 | DCTPP1 (0.38) | DCTPP1CYP2C9CYP2C19CYP3A4KCNH2 | |
| SCHEMBL31714935 | 0.89 | CYP2C9 (0.33) | CYP2C9CYP2C19CYP3A4KCNH2CYP2D6 | |
| SCHEMBL31714865 | 0.88 | CYP2C9 (0.36) | DCTPP1CYP2C9CYP2C19CYP3A4KCNH2 | |
| SCHEMBL12311043 | 0.85 | CYP2C9 (0.39) | CYP2C9CYP2C19CYP3A4KCNH2CYP2D6 | |
| SCHEMBL31714623 | 0.85 | CYP2C9 (0.39) | CYP2C9CYP2C19CYP3A4KCNH2CYP2D6 | |
| SCHEMBL31714678 | 0.83 | CYP2C9 (0.38) | DCTPP1CYP2C9CYP2C19CYP3A4KCNH2 | |
| SCHEMBL31714902 | 0.80 | CYP2C9 (0.38) | CYP2C9CYP2C19CYP3A4KCNH2CYP2D6 | |
| SCHEMBL31714981 | 0.78 | YTHDC1 (0.42) | CYP2C9CYP2C19CYP3A4KCNH2CYP2D6 | |
| SCHEMBL31714943 | 0.78 | DCTPP1 (0.35) | DCTPP1CYP2C9CYP2C19CYP3A4KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250333424-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2025-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250333424-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, IRF3 | DCTPP1 142/4885CYP2C9 2850/4885CYP2C19 3152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.